Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 436

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 436
---
 future products may have a material adverse impact on the company.

If third parties prepare and file patent applications in the United States that also claim technology to which TuHURA has rights, TuHURA may have to participate in interference or derivation proceedings in the USPTO to determine priority of invention. For more information, see “Risk Factors—Risks Relating to TuHURA – Risks Relating to TuHURA’s Intellectual Property.”

<div align='center'>267</div>

When available to expand market exclusivity, TuHURA’s strategy is to obtain, or license additional intellectual property related to current or contemplated development platforms, core elements of technology and/or clinical candidates. Company-owned Intellectual Property As of December 31, 2024, TuHURA had 33 issued patents over 13 jurisdictions, and 9 pending applications (2 U.S. utility patent applications and 7 foreign patent applications). Most of such patents and patent applications relate to TuHURA’s IFx technology platform. The following is a summary of TuHURA’s issued patents and pending patent applications as of December 31, 2024 by patent family.

| Patent Family                                             |     | Description                                                                                                  |     | Application/                             
 Publication/                             
 Patent Number                            |     | Filing     
 Date       |     | Issue Date/Status |     | Earliest   
 Expected   
 Expiration 
 Date       |     | Type of      
 Parent       
 Protection   |
| DNA Vector and Transformed Tumor Cell Vaccines            |     | Whole cell and DNA cancer vaccines                                                                           |     | PCT/US2015/018688                        
 (WO 2015/134577)                         |     | 03/04/2015 |     | Nationalized in   
 CH, DE, DK, EP,   
 FR, GB, HK, IE,   
 NL, NO, SE, US    |     | 3/4/2035   |     | Use          
 Composition  
 Composition  |
|                                                           |     |                                                                                                              |     | US 9,555,088                             
 US 9,839,680 US 10,391,158 US 10,751,400 |     | 07/07/2016 
 01/30/2017 
 12/11/2017 
 08/26/2019 |     | Issued 01/31/2017 
 Issued 12/12/2017 
 Issued 08/27/2019 
 Issued 08/